BRIEF-Onconova enrolls first patient in Europe for Phase 3 trial of rigosertib

* Enrolls first patient in Europe for Phase 3 Inspire trial of rigosertib in higher-risk myelodysplastic syndromes
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.